Selective natrexone-derived opioid receptor antagonists

A. E. Takemori, Philip S Portoghese

Research output: Contribution to journalReview article

125 Citations (Scopus)

Abstract

Progress in opioid research relies heavily on ligands as probes to evaluate selectivity of action. The design of such ligands using naltrexone as a precursor has afforded a number of highly selective antagonists. These include the κ opioid receptor antagonist, norBNI, and δ opioid receptor antagonists, NTI and NTB. The unifying concept in the development of these antagonists was the enhancement of selectivity through simultaneous occupation of two neighboring recognition sites by a single ligand. These selective naltrexone-derived antagonists have been used widely to study the involvement of κ and δ opioid receptors in a variety of pharmacologic, physiologic, and biochemical effects.

Original languageEnglish (US)
Pages (from-to)239-269
Number of pages31
JournalAnnual Review of Pharmacology and Toxicology
Volume32
StatePublished - Jun 5 1992

Fingerprint

Narcotic Antagonists
Naltrexone
Ligands
Opioid Receptors
Occupations
Opioid Analgesics
Research

Keywords

  • antagonists
  • delta
  • kappa
  • naltrexone
  • opioid receptors

Cite this

Selective natrexone-derived opioid receptor antagonists. / Takemori, A. E.; Portoghese, Philip S.

In: Annual Review of Pharmacology and Toxicology, Vol. 32, 05.06.1992, p. 239-269.

Research output: Contribution to journalReview article

@article{bc5394fb931249f7a3aa7ee66e3aada6,
title = "Selective natrexone-derived opioid receptor antagonists",
abstract = "Progress in opioid research relies heavily on ligands as probes to evaluate selectivity of action. The design of such ligands using naltrexone as a precursor has afforded a number of highly selective antagonists. These include the κ opioid receptor antagonist, norBNI, and δ opioid receptor antagonists, NTI and NTB. The unifying concept in the development of these antagonists was the enhancement of selectivity through simultaneous occupation of two neighboring recognition sites by a single ligand. These selective naltrexone-derived antagonists have been used widely to study the involvement of κ and δ opioid receptors in a variety of pharmacologic, physiologic, and biochemical effects.",
keywords = "antagonists, delta, kappa, naltrexone, opioid receptors",
author = "Takemori, {A. E.} and Portoghese, {Philip S}",
year = "1992",
month = "6",
day = "5",
language = "English (US)",
volume = "32",
pages = "239--269",
journal = "Annual Review of Pharmacology and Toxicology",
issn = "0066-4251",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Selective natrexone-derived opioid receptor antagonists

AU - Takemori, A. E.

AU - Portoghese, Philip S

PY - 1992/6/5

Y1 - 1992/6/5

N2 - Progress in opioid research relies heavily on ligands as probes to evaluate selectivity of action. The design of such ligands using naltrexone as a precursor has afforded a number of highly selective antagonists. These include the κ opioid receptor antagonist, norBNI, and δ opioid receptor antagonists, NTI and NTB. The unifying concept in the development of these antagonists was the enhancement of selectivity through simultaneous occupation of two neighboring recognition sites by a single ligand. These selective naltrexone-derived antagonists have been used widely to study the involvement of κ and δ opioid receptors in a variety of pharmacologic, physiologic, and biochemical effects.

AB - Progress in opioid research relies heavily on ligands as probes to evaluate selectivity of action. The design of such ligands using naltrexone as a precursor has afforded a number of highly selective antagonists. These include the κ opioid receptor antagonist, norBNI, and δ opioid receptor antagonists, NTI and NTB. The unifying concept in the development of these antagonists was the enhancement of selectivity through simultaneous occupation of two neighboring recognition sites by a single ligand. These selective naltrexone-derived antagonists have been used widely to study the involvement of κ and δ opioid receptors in a variety of pharmacologic, physiologic, and biochemical effects.

KW - antagonists

KW - delta

KW - kappa

KW - naltrexone

KW - opioid receptors

UR - http://www.scopus.com/inward/record.url?scp=0026462183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026462183&partnerID=8YFLogxK

M3 - Review article

VL - 32

SP - 239

EP - 269

JO - Annual Review of Pharmacology and Toxicology

JF - Annual Review of Pharmacology and Toxicology

SN - 0066-4251

ER -